Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
147,844,682
-
Share change
-
-2,296,885
-
Total reported value
-
$7,903,754,877
-
Put/Call ratio
-
64%
-
Price per share
-
$53.46
-
Number of holders
-
298
-
Value change
-
-$103,617,443
-
Number of buys
-
150
-
Number of sells
-
123
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q4 2020
As of 31 Dec 2020,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) was held by
298 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
147,844,682 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, FRED ALGER MANAGEMENT, LLC, Palo Alto Investors LP, and D. E. Shaw & Co., Inc..
This page lists
298
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.